Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249605 | SCV000312164 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000344542 | SCV000383387 | likely benign | Charlevoix-Saguenay spastic ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000465285 | SCV000562832 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676375 | SCV001897054 | benign | not provided | 2018-10-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676375 | SCV005219362 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676375 | SCV000802151 | benign | not provided | 2016-02-22 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000344542 | SCV001453567 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000249605 | SCV001953828 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000249605 | SCV001973834 | benign | not specified | no assertion criteria provided | clinical testing |